← Open Payments lookup

MICHAEL RASMUSSEN: Open Payments

NPI 1487056339 · GARLAND, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$209 in 9 payments from 7 companies in 2025. Trend: 2023 $219 · 2024 $293 · 2025 $209

Food & beverage: $209
CompanyPaymentsAmount
Boehringer Ingelheim Pharmaceuticals, Inc.3$80
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$35
Seqirus USA Inc1$23
ABBVIE INC.1$20
Kowa Pharmaceuticals America, Inc.1$19
Dexcom, Inc.1$18
Novo Nordisk Inc1$15

Products named: JARDIANCE, CAPLYTA, Fluad, VRAYLAR, ZORYVE, Dexcom G6 Transmitter, Ozempic.

Industry payments across UT — which companies pay providers there.